Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02464514 · ClinicalTrials.gov registry record · NA
Macronutrient Regulation of Ghrelin and Peptide YY
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02464514 is a NA study that has completed, run by Duke University. The registered enrollment target is 28 participants.
The verdict
NCT02464514, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The hyperghrelinemia of children with PWS provides a unique model by which to explore the hormonal and metabolic effects of orexigenic hormones in normal and pathologic conditions. An important question to be addressed by this proposed research includes the macro-nutrient regulation of ghrelin and PYY in obese children and children with PWS. As ghrelin antagonists are considered potential future anti-obesity agents, it is essential to gain understanding of the developmental, nutritional and hormonal regulation of this important orexigenic hormone in children.
Interventions
- OTHER High fat meal
- OTHER High carbohydrate meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2004-01 |
| Est. Completion | 2005-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02464514
The ClinicalTrials.gov registry entry for NCT02464514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High fat meal is the first listed.
NCT02464514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02464514 about?
NCT02464514 is a clinical study titled "Macronutrient Regulation of Ghrelin and Peptide YY". The hyperghrelinemia of children with PWS provides a unique model by which to explore the hormonal and metabolic effects of orexigenic hormones in normal and pathologic conditions. An important question to be addressed by this proposed research includes the macro-nutrient regulation of ghrelin and P...
What is the current status of trial NCT02464514?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2004-01. Estimated completion is 2005-12.
What interventions are being tested in trial NCT02464514?
The interventions under investigation include: High fat meal (OTHER), High carbohydrate meal (OTHER).
Who is sponsoring clinical trial NCT02464514?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.